Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colorectal Neoplasms × High-Intensity Interval Training × Clear all

Phase

Status

Unknown 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 8 Motor Activity 7 Prostatic Neoplasms 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Insulin Resistance 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Diabetes Mellitus, Type 1 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1

Interventions

Fluorouracil 233 Leucovorin 206 Oxaliplatin 196 Irinotecan 184 Bevacizumab 178 Capecitabine 130 Cetuximab 116 Panitumumab 59 Folfox protocol 59 regorafenib 45 pembrolizumab 37 IFL protocol 36 Colonoscopy 36 Nivolumab 30 Radiotherapy 29 Drug Therapy 25 Blood Specimen Collection 23 Gemcitabine 21 trifluridine tipiracil drug combination 19 Chemotherapy, Adjuvant 19 Surveys and Questionnaires 16 Neoadjuvant Therapy 15 Celecoxib 15 durvalumab 14 Surgical Procedures, Operative 14 Cyclophosphamide 14 Erlotinib Hydrochloride 13 Cisplatin 13 aflibercept 12 tremelimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04715061 2022-11-07

CANEX-2

Université de Sherbrooke

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡